Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Supply – Local Anesthetic Injection

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
36E79726R0032 Lisinopril Tablets (VA-27-00004937)
Solicitation # 36E79726R0032
The Department of Veterans Affairs is conducting an unrestricted procurement under solicitation 36E79726R0032 to secure an uninterrupted source of supply for Lisinopril Tablets. This contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four pre-priced one-year option periods. The procurement is issued in a commercial item format in accordance with FAR Part 12, with a tentative solicitation release date of September 3, 2026, and a response deadline of September 24, 2026. The scope of work includes the supply of Lisinopril tablets in various strengths ranging from 2.5mg to 40mg, with specific annual quantity requirements for various bottle sizes. Strict packaging and labeling standards are mandated, requiring a unique NDC number and the exact drug name on the label. For specific unit-of-use packaging, bottles must be cylindrical with a minimum 120cc volume and a 5.75 inch circumference to accommodate a 5.25 by 2 inch label. Additionally, these bottles must feature a safety cap that is either convertible or deshellable. The contractor's label must be the only label on the product and must allow VA labels to adhere securely on top. All proposals and communications are handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

about 21 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

The contract requires the supply of FDA-approved Bupivacaine and Epinephrine Injection that fully complies with the National Stock Number 6505-01-189-3973 specifications, ensuring the product meets exact pharmaceutical and performance standards required for military use. The injection must adhere to rigorous military packaging, labeling, and delivery protocols, including proper storage, documentation, and transport conditions to maintain integrity and compliance throughout the supply chain. The product is intended for use by the Department of Defense and must be delivered to the designated performance location in FPO with ZIP code 96674. This subcontract, posted on July 16, 2026, has a response deadline of July 22, 2026, and falls under NAICS code 325412, which classifies it within the pharmaceutical and medicine manufacturing sector. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating the stringent oversight and regulatory expectations for quality, consistency, and reliability. All suppliers must ensure complete adherence to federal and military requirements without exception, as noncompliance will result in rejection of the bid or delivery. The contract is accessible via the DIBBS platform for further details and submission.

General Info

Supply FDA-approved Bupivacaine and Epinephrine Injection per NSN 6505-01-189-3973 for DoD delivery to FPO 96674.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AP, 96674, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4169.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

BUPIVACAINE AND EPINEP

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of FDA-approved Bupivacaine and Epinephrine Injection meeting NSN 6505-01-189-3973 specifications, compliant with military packaging, labeling, and delivery standards.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency